AzTrials
AzTrials

Neurodevelopmental DisordersNCT05803252

Videoconferencing-based Focused Acceptance and Commitment Therapy for Parents of SHCN Children

A study testing Focused Acceptance and Commitment Therapy in people with Neurodevelopmental Disorders and Attention Deficit Hyperactivity Disorder, run by Chinese University of Hong Kong at 5 sites in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the proposed non-randomized waitlist-controlled design study is to evaluate the feasibility, acceptability, and potential effectiveness of using a Videoconferencing-based Individual Focused Acceptance and Commitment Therapy (FACT) approach to enhance the mental well-being of parents of children with… Read more about this study

Who is it for?
Ages 21 years and older
What is being tested?
Focused Acceptance and Commitment Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
104 participants
Where
5 sitesHong Kong
Study dates
15 Mar 2023to 28 Feb 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Cantonese-speaking Hong Kong residents aged ≥21 years;
  • living together with the child who is at preschool/school-age (3-9 years old);
  • adopt the responsibility of taking care of the child;
  • access to reliable Internet access via either computers and/or smartphones and be committed to maintaining internet access for the duration of the intervention
  • In addition, potential eligible parents who respond "yes" to any of the five validated screening questions in the Children with Special Health Care Needs (SHCN) Screener will then be asked the associated follow-up questions to determine whether the child possesses physical, neurodevelopmental/emotional problem(s) that has lasted for at least 12 months. Only children with a positive response(s) to ≥ 1 item in each of the associated follow-up questions will be classified as children with SHCN

Who cannot join

  • Parents with cognitive deficiency, severe mental illness and/or disability conditions that interfere with their ability to comprehend the programme's content
  • had substance/alcohol dependency problems,
  • are pregnant;
  • are less than six months postpartum

Trial locations and contacts

5 sites in 1 country.

5 sites in 1 country

Hong Kong5 sites
  • Hong Kong Christian Service

    Hong Kong

  • Hong Kong Federation of Youth Groups

    Hong Kong

  • Hong Kong Young Women's Christian Association

    Hong Kong

  • Yang Memorial Methodist Social Service

    Hong Kong

  • Chinese University of Hong Kong

    Shatin

Other trials in Hong Kong

About this study

Official title: Videoconferencing-based Focused Acceptance and Commitment Therapy for Parents of Children With Special Health Care Needs: A Non-randomised Controlled Feasibility Trial

The purpose of the proposed non-randomized waitlist-controlled design study is to evaluate the feasibility, acceptability, and potential effectiveness of using a Videoconferencing-based Individual Focused Acceptance and Commitment Therapy (FACT) approach to enhance the mental well-being of parents of children with special healthcare needs (SHCN) over a three-month period after the intervention has taken place.

Read the detailed description

Parents of children with special health care needs (SHCN) have always been under tremendous pressure to care for their children. The parental well-being, as well as family functioning, are at risk. In literature, there has been increasing evidence supporting the efficacy of Acceptance and Commitment Therapy (ACT) on mental health in different populations, including healthy individuals, parents, children and those with mental health problems. The previous studies done by the PI in using ACT for improving parental well-being and management have proven the intervention effective for Hong Kong parents. Her work showed that ACT training effectively enhanced the parental well-being of parents of children with asthma and autism spectrum disorder.

Though the result was promising, the previous clinical trials in Hong Kong showed a limited effect size. This is due to the need for extensive manpower in ACT intervention, yet there are very limited trained ACT interventionists in Hong Kong. On top of that, past interventions have failed to target impaired psychopathological processes as well as identify and determine which psychopathological processes require intervention in the first place. This study aims to overcome the limitations mentioned above. The proposed study will follow the model and principles of Focused Acceptance Commitment Therapy (FACT) to increase the psychological flexibility of parents of children with SHCN. FACT is a new model of brief therapy that is a highly condensed version of Acceptance and Commitment Therapy, which has been proven to be effective in the long term in improving one's mental well-being through increasing one's psychological flexibility. The time-limited and brief FACT intervention targets the impaired psychopathological processes and determines what process(es) need to work on first, which also eases the demand for ACT interventionists.

This study aims to evaluate the feasibility, acceptability, and possible effectiveness of Videoconferencing-based Individual Focused Acceptance and Commitment Therapy (FACT) in enhancing the mental health of parents of children with special healthcare needs (SHCN) by comparing the results to those of a waitlist control group. The study will assess the well-being of the participating parents before the intervention, immediately after the intervention and again three months later to determine the impact of the FACT intervention on their mental well-being.

Being tested
Focused Acceptance and Commitment Therapy, Waitlist Control
Keywords
Special health care needs (SHCN), Parental well-being, Family functioning, Acceptance and Commitment Therapy (ACT), Hong Kong, Focused Acceptance Commitment Therapy (FACT), Psychological flexibility, Feasibility, Acceptability, Waitlist control group, Mental well-being
Medical subject headings
Neurodevelopmental Disorders, Attention Deficit Disorder with Hyperactivity, Autism Spectrum Disorder, Learning Disabilities, Chronic Disease, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Focused Acceptance and Commitment TherapyBehavioural

    FACT aims to increase one's psychological flexibility so that one will not generate feelings of distress and suffering when confronted with painful life situations. The intervention of this study will follow the FACT principles laid out by Strosahl, Robinson and Gustavsson to increase parents' psychological flexibility. Three core processes influence one's psychological flexibility: awareness, openness, and engagement.

    The key objectives of each core process are:

    1. Awareness: Able to experience the present moment, able to take perspective on self
    2. Openness: Able to detach distressing private experiences and associated rules, able to take a non-judgemental, accepting stance towards painful material
    3. Engagement: Exhibits strong connection with values, able to sustain values-consistent action
  • Waitlist ControlOther

    The waitlist control group participants will commence their FACT intervention immediately after they complete their follow-up assessment.

Study groups in NCT05803252
Study groupRoleWhat they receive
FACT GroupExperimental4-6 FACT consultation sessions, one weekly session, 45-60 mins per session. These sessions will be using online video conferencing platforms.
Receives: Behavioral: Focused Acceptance and Commitment Therapy
Waitlist Control GroupOtherThe waitlist control group participants will commence their intervention trial immediately after they complete their follow-up assessment.
Receives: Other: Waitlist Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Parental depressive symptoms

    The Patient Health Questionnaire (PHQ-9, 9-item, 4-point Likert scale) will be used to assess the frequency of the parents experiencing depressive symptoms in the past two weeks. The Chinese version of the PHQ-9 has demonstrated good internal consistency reliability (Cronbach's alpha = 0.86) and test-retest correlation coefficient.

    Measured: Change from baseline assessment to immediate and 3 months post-intervention

  2. Parental anxiety symptoms

    The Generalized Anxiety Disorder-7 (GAD-7, 7-item, 4-point Likert scale) will be used to measure the severity of anxiety symptoms. The Chinese version of the GAD-7 demonstrated good reliability and validity with a Cronbach's coefficient of 0.91.

    Measured: Change from baseline assessment to immediate and 3 months post-intervention

  3. Parental Stress

    The Parental Stress Scale (PSS, 18-item, 5-point scale) will assess parenting stress. A higher score represents a higher level of parental stress. The Chinese version of the PSS has demonstrated acceptable psychometric properties and is therefore suitable for use by researchers to assess the parental stress levels of Chinese parents.

    Measured: Change from baseline assessment to immediate and 3 months post-intervention

Secondary outcomes (1)
  1. Parental Psychological Flexibility

    The PsyFlex (5-point Likert scale, 6 items) will be used to assess the six therapeutic processes in ACT, namely contacting the present moment, defusion, acceptance, self-as-context, values and committed action.

    Measured: Change from baseline assessment to immediate and 3 months post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Apr 2023
  2. Study start15 Mar 2023
  3. Primary completion30 Dec 2025
  4. Study completion28 Feb 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Assigned by the investigator but not randomized
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
104 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05803252
Sponsor's protocol ID
NTEC-2023-058
Status last verified
Mar 2026
First submitted
26 Mar 2023
Last updated
5 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Focused Acceptance and Commitment Therapy in people with Neurodevelopmental Disorders and Attention Deficit Hyperactivity Disorder, run by Chinese University of Hong Kong at 5 sites in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Parental depressive symptoms (time frame: Change from baseline assessment to immediate and 3 months post-intervention). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in